Haaartland

Login
Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients - Full Text View - ClinicalTrials.gov

inbrighter - #type2diabetes

Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients - Full Text View - ClinicalTrials.gov

Source: Clinicaltrials

Bo

Bo

Your sidekick
Sweden

Bo
Your sidekick

  • 0

Primary Outcome Measures: Percentage change from baseline HbA1c [ Time Frame: 3 months ] Demonstrate that the addition of mealtime Afrezza can significantly lower HbA1c within 3 months in uncontrolled type 2 diabetes patients initially having HbA1c of 8 or higher, despite at least 6 months of prior therapy with diabetes medications.

View original